Posts by: Marisa Wexler, MS

Marisa Wexler, MS

Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.

August 31, 2020August 31, 2020

AbbVie Seeks FDA, EMA Approvals of Rinvoq for Active AS

News

AbbVie has submitted an application to the U.S. Food and Drug Administration (FDA) requesting the approval of Rinvoq (upadacitinib) for the treatment of adults with active ankylosing spondylitis (AS). ... Read more

July 29, 2020July 29, 2020

EU Approves Under-the-skin Remsima Injectable for 5 Autoimmune Disorders

News

An under-the-skin injectable formulation of Remsima (infliximab), called Remsima SC, has been approved in European Union for the treatment of five autoimmune disorders, including ankylosing spondylitis. The approval by the European ... Read more

July 20, 2020July 20, 2020

Mindfulness Linked to Reduced Fatigue-associated Disability in Arthritis

News

On days when they are more mindful or engaged in meaningful activities, people with ankylosing spondylitis or rheumatoid arthritis experience less impairment due to fatigue, a study suggests. The ... Read more

June 8, 2020July 20, 2020

FDA Approves Taltz for Non-radiographic Axial Spondyloarthritis

News

Eli Lilly‘s Taltz (ixekizumab) has been approved in the U.S. to treat non-radiographic axial spondyloarthritis (nr-axSpA) in people who have objective signs of inflammation. “This approval reflects Lilly’s continued ... Read more

May 4, 2020May 4, 2020

Humira, Smoking Can Alter Gut Microbiome in AS, Study Finds

News

Both treatment with Humira (adalimumab) and smoking can alter the composition of the gut microbiome — the microorganisms living in the gut — in people with ankylosing spondylitis (AS), a new study ... Read more

April 27, 2020April 27, 2020

High Levels of Protein Found in Bones and Gut May Link AS and IBD

News

Elevated levels of a protein produced in both bones and the gut, known as lipocalin 2 (LCN2), could explain the overlap between ankylosing spondylitis (AS) and inflammatory bowel disease ... Read more

April 20, 2020April 20, 2020

TNF Inhibitor Use May Raise Risk of MS and Neuropathy in AS Patients

News

Use of tumor necrosis factor alpha (TNF) inhibitors is linked to a higher risk of inflammatory disorders affecting the nervous system among people with ankylosing spondylitis (AS) and psoriatic arthritis ... Read more

April 6, 2020April 6, 2020

CHMP Supports Cosentyx’s Approval in Europe to Treat nr-axSpA

News

The Committee for Medicinal Products for Human Use (CHMP) is recommending the approval of Cosentyx (secukinumab) for the treatment of adults with active non-radiographic axial spondyloarthritis (nr-axSpA). Recommendations from ... Read more

March 30, 2020March 30, 2020

CHMP Recommends Enbrel Biosimilar Nepexto for Approval in Europe

News

The Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Nepexto, a biosimilar of Enbrel (etanercept), for the treatment of various inflammatory disorders including ankylosing spondylitis. CHMP ... Read more

February 13, 2020February 13, 2020

Health Canada Approves Taltz for Treatment of Active Ankylosing Spondylitis

News

Health Canada approved Taltz (ixekizumab) for the treatment of adults with active ankylosing spondylitis (AS) who have responded poorly to or are unable to tolerate conventional therapies. Eli Lilly‘s ... Read more

Pin It on Pinterest